Technetium Tc-99m Sestamibi
Technetium Tc-99m Sestamibi is a pharmaceutical drug with 7 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
0
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
3
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer
SPECT/CT for the Characterization of Renal Masses
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities
A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects
Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty
Clinical Trials (7)
DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer
SPECT/CT for the Characterization of Renal Masses
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities
A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects
Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty
CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI
A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease.
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7